Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.
Ahmad Kiadaliri, Aliasghar LU
; Gerdtham, Ulf
LU
; Eliasson, Bjorn
and Steen Carlsson, Katarina
LU
(2014)
In Diabetes therapy : research, treatment and education of diabetes and related disorders
5(2).
p.591-607
- Abstract
- This study aimed to assess the costs and benefits of three alternative second-line treatment strategies for Swedish patients with type 2 diabetes mellitus (T2DM) who fail to reach glycated hemoglobin (HbA1c) ≤ 7% with metformin treatment alone: glucagon-like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and neutral protamine Hagedorn (NPH) insulin.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4691822
- author
- Ahmad Kiadaliri, Aliasghar
LU
; Gerdtham, Ulf
LU
; Eliasson, Bjorn
and Steen Carlsson, Katarina
LU
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Diabetes therapy : research, treatment and education of diabetes and related disorders
- volume
- 5
- issue
- 2
- pages
- 591 - 607
- publisher
- Springer
- external identifiers
-
- pmid:25213800
- scopus:84919617689
- pmid:25213800
- wos:000209718400019
- ISSN
- 1869-6953
- DOI
- 10.1007/s13300-014-0080-0
- language
- English
- LU publication?
- yes
- id
- bfa68c70-de5f-4f5f-a765-7e7d34ec5ab2 (old id 4691822)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25213800?dopt=Abstract
- date added to LUP
- 2016-04-01 13:31:42
- date last changed
- 2023-10-01 03:02:10
@article{bfa68c70-de5f-4f5f-a765-7e7d34ec5ab2,
abstract = {{This study aimed to assess the costs and benefits of three alternative second-line treatment strategies for Swedish patients with type 2 diabetes mellitus (T2DM) who fail to reach glycated hemoglobin (HbA1c) ≤ 7% with metformin treatment alone: glucagon-like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and neutral protamine Hagedorn (NPH) insulin.}},
author = {{Ahmad Kiadaliri, Aliasghar and Gerdtham, Ulf and Eliasson, Bjorn and Steen Carlsson, Katarina}},
issn = {{1869-6953}},
language = {{eng}},
number = {{2}},
pages = {{591--607}},
publisher = {{Springer}},
series = {{Diabetes therapy : research, treatment and education of diabetes and related disorders}},
title = {{Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.}},
url = {{https://lup.lub.lu.se/search/files/3431348/5277028}},
doi = {{10.1007/s13300-014-0080-0}},
volume = {{5}},
year = {{2014}},
}